Chemical Compound
(2S,3R,4S,5S,6R)-2-((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-((1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-6-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl)oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
CAS Registry Number
52286-58-5
Primary record
(2S,3R,4S,5S,6R)-2-((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-((1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-6-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl)oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- 库存
- 1,607 克
- 纯度
- 98.5 %
- CAS
- 52286-58-5
化合物标识与属性
- CAS
- 52286-58-5
- PubChem CID
- 441922
- SMILES
- CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O)C)O)C
- Canonical SMILES
- CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@]12C
名称与同义词
- Ginsenoside Rf
- Panaxoside RF
- GinsenosideRf
- 52286-58-5
- ginsenoside-rf
- GINSENOSIDE- RF
- JOS8BON5YW
- UNII-JOS8BON5YW
- RefChem:37706
- 20(S)-ginsenoside Rf
- AC1L9BXN
- Ginsenoside Rf (Standard)
- MFCD00210509
- CHEBI:67986
- DTXSID90904205
- orb1300211
- CHEMBL1773987
- SCHEMBL22607970
- HY-N0601R
- WLZ4721
- C42H72O14
- DTXCID101333354
- Ginsenoside Rf, analytical standard
- HY-N0601
- MSK40274
- CID441922
- AKOS027251120
- ZINC238809500
- ACN-035582
- CID:441922
- CS-3841
- EBC-615933
- OG09284
- C42-H72-O14
- GINSENOSIDE RF (REFERENCE GRADE)
- AN-41075
- AS-56543
- DA-63765
- SC-46561
- SID:53790417
- J108.021K
- FT-0777128
- N1917
- X1153
- C08945
- 286G585
- A829009
- C055328
- (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- Q27104950
- Ginsenoside Rf, primary pharmaceutical reference standard
- B0005-465147
- Ginsenoside Rf, 98%, from Panax ginseng C. A. Mey. - 5MG 5mg
- (2S,3R,4S,5S,6R)-2-{[(2R,3R,4S,5S,6R)-2-{[(1S,3aR,3bR,5S,5aR,7S,9aR,9bR,11R,11aR)-7,11-dihydroxy-1-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-5-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
- (3b,6a,12b)-3,12,20-Trihydroxydammar-24-en-6-yl-2-O-(b-D-glucopyranosyl)-b-D-glucopyranoside
- beta-D-Glucopyranoside, (3beta,6alpha,12beta)-3,12,20-trihydroxydammar-24-en-6-yl 2-O-beta-D-glucopyranosyl-
- (20S)-6alpha-(2-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyloxy)-5alpha-dammara-24-ene-3beta,12beta,20-triol
- (20S)-6alpha-(2-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyloxy)-5alpha-dammara-24-ene-3beta,20,12beta-triol
- (2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-17-((S)-2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-6-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
- (2S,3R,4S,5S,6R)-2-((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-((1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-6-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl)oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- (2S,3R,4S,5S,6R)-2-((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-((2S)-2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-6-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl)oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-
- (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- (3|A,6|A,12|A)-3,12,20-Trihydroxydammar-24-en-6-yl 2-O-|A-D-glucopyranosyl-|A-D-glucopyranoside
- (beta,6alpha,12beta)-3,12,20-trihydroxydammar-24-en-6-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
- .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,6.ALPHA.,12.BETA.)-3,12,20-TRIHYDROXYDAMMAR-24-EN-6-YL 2-O-.BETA.-D-GLUCOPYRANOSYL-
- [3beta,12beta,20-Trihydroxy-5alpha-dammar-24-en-6alpha-yl]2-O-(beta-D-glucopyranosyl)-beta-D-glucopyranoside
- [3beta,12beta,20-Trihydroxydammar-24-en-6alpha-yl]2-O-(beta-D-glucopyranosyl)-beta-D-glucopyranoside
- 3beta,12beta,20-Trihydroxy-5alpha-dammara-24-ene-6alpha-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
- 3beta,12beta,20-Trihydroxydammar-24-en-6alpha-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
- 3beta,12beta,20-Trihydroxydammara-24-ene-6alpha-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
- 634-870-3
- GINSENOSIDE RF (CONSTITUENT OF AMERICAN GINSENG, ASIAN GINSENG, AND TIENCHI GINSENG) [DSC]
- ss-D-Glucopyranoside, (3ss,6a,12ss)-3,12,20-trihydroxydammar-24-en-6-yl 2-O-ss-D-glucopyranosyl-; Dammarane, ss-D-glucopyranoside deriv.; (3ss,6a,12ss)-3,12,20-Trihydroxydammar-24-en-6-yl 2-O-ss-D-glucopyranosyl-ss-D-glucopyranoside; Ginsenoside Rf; Panaxoside Rf